Muscle relaxants and stomach positioning for ARDS
Part of Lungs & breathing clinical trials.
This trial tests whether combining two treatments—medications that relax muscles (neuromuscular blocking agents) and lying on your stomach (prone positioning)—can reduce lung damage in people with severe ARDS on a breathing machine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a family member or legal representative who can give written consent for you to join the study.
- You must be on a breathing tube (invasive mechanical ventilation) for 72 hours or less.
- You must have moderate to severe ARDS (a serious lung injury).
- You must be covered by social security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two ways to adjust ventilator settings for patients with severe lung injury whose oxygen levels are very low. It aims to find out the best level of breathing support and whether giving muscle relaxants during prone positioning helps improve oxygen levels.
This study is testing whether different levels of muscle relaxation (called neuromuscular blockade) during breathing support can improve lung function in people with serious ARDS. It might help doctors choose the best relaxation level for patients on a breathing machine.
This trial tests if longer periods of lying face-down (prone positioning) can help people with ARDS who are on a breathing machine. It aims to improve oxygen levels and possibly reduce the need for more invasive treatments.
This trial is testing whether adding inhaled nitric oxide to lying on your stomach (prone position) can help people with severe lung failure (ARDS) who are on a ventilator. It uses a special monitor (EIT) to check lung function in real time.
This trial studies how lying face down (prone position) affects breathing in patients with acute respiratory distress syndrome (ARDS). It may help doctors better monitor and treat patients on a breathing machine.
This trial compares two ways of giving muscle-relaxing medication to patients on breathing machines with severe lung injury. The study tests whether one approach helps patients breathe better or recover faster than the other.
Hear when a new Moderate to Severe Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.